ArticleFrontiers in oncology2021

Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma.

Liuning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.